NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

Thank you first of all for reading and appreciating my posts.

Please allow me to explain. First of all most biotechs are valued at face value to the potential of the market they are digging in. The GBM for 2017 is not 1,15 billion its far less; 1,15 billion is for 2024, 6 years from now. So to value a company for receiving SOC at approx 1 billion which is 50% of the revenue (not net profit) it could receive in 2024 is already a stretch. A lot of bio's are valued far less than the complete market revenue it could gain given the product it has been approved for.

NWBO should, could and will be valued at a much better price than what I value it right after FDA approval IF the following conditions or a combination of them will take place:
1. NWBO should additionally have a lucrative royalty deal with keytruda, BMY or other BP (NWBO should prove the market there is no more need of hundreds of millions of new shares to be issued for its future operations after approval)
2. NWBO should additionally have the (next phase) DCVAX Direct trial solid and funded in place and on its way!
3. NWBO should have the combo trial solid and funded in place and on its way.

If NWBO proves its worth more than just GBM than the MC will rise to bigger heights, the market will not just speculate on it or take NWBO's word for it.

IMO